Establishment of a Cell-Based Drug Screening Model for Identifying Down-Regulators of Protein Tyrosine Phosphatase 1B Expression

Abstract

Protein Tyrosine Phosphatase 1B (PTP1B), an important negative regulator of insulin signaling, is thought to be an attractive therapeutic target for insulin resistance and type 2 diabetes. For the aim of screening PTP1B expression down-regulators, we established the drug screening cellular model based on transcriptional regulation of PTP1B. In this study, the promoter sequences of PTP1B were cloned into pGL3B-neo vector containing luciferase gene and neomycin resistance gene. The recombinant reporter gene vector pGL3B-neo /PTP1B was transfected into CV1 cells and therefore stable cell line, namely SPTP1B, was obtained. With the cell-based reporter gene assay, we detected more than one hundred compounds in microtiter wells. In the screening process, the compound CM107 which had extracted from the traditional Chinese medicinal herbs was identified to repress the activity of PTP1B promoter significantly in mode of dose-dependence.

Key words

diabetes<autoimmunity - insulin resistance - protein tyrosine phosphatase 1B

References

• 1 Ahmad F, Azevedo JJ, Cortright R, Dohm G, Goldstein B. Alterations in skeketal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.  J Clin Invest. 1997;  100 449-458
• 2 Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ. Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein tyrosine phosphatase in adipose tissue.  Metabolism. 1997;  46 1140-1145
• 3 Ahmad F, Li PM, Meyerovitch J, Goldstein BJ. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.  J Biol Chem. 1995;  270 20503-20508
• 4 Amacker-Francoys I, Mohanty S, Niessen M, Spinas GA, Trüb T. The metabolisable hexoses D-glucose and D-mannose enhance the expression of IRS-2 but not of IRS-1 in pancreatic ß-cells.  Exp Clin Endocrinol Diabetes. 2005;  113 423-429
• 5 Baumann CA, Saltiel AR. Spatial compartmentalization of signal transduction in insulin action.  BioEssays. 2001;  23 215-222
• 6 Bjornholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.  Diabetes. 1997;  46 524-527
• 7 Chen H, Cong LN, Li Y, Yao ZJ, Wu L, Zhang ZY, Burke TR, Quon MJ. A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells.  Biochemistry. 1999;  38 384-389
• 8 Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Ash MB, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in L6 myocytes and Fao hepatoma cells.  J Biol Chem. 2001;  276 10207-10211
• 9 Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Hagen JH, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. Incerased insulin sensitivity and obessity resistance in mice lacking the protein tyrosine phosphatase-1B gene.  Science. 1999;  283 1544-1548
• 10 Forsell PKAL, Boie Y, Montalibet J, Collins S, Kennedy BP. Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes.  Gene. 2000;  260 145-153
• 11 Fukada T, Tonks NK. The Reciprocal Role of Egr-1 and Sp Family Proteins in Regulation of the PTP1B Promoter in Response to the p210 Bcr-Abl Oncoprotein-tyrosine Kinase.  J Biol Chem. 2001;  276 25512-25519
• 12 Goldstein BJ, Bittnerkowalczyk A, White MF, Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.  J Biol Chem. 2000;  275 4283-4289
• 13 Kahn BB, Flier JS. Obesity and insulin resisitance.  J Clin Inv. 2000;  106 473-481
• 14 Kennedy BP. Role of protein tyrosine phosphatase-1B in diabetes and obesity.  Biomed & Pharmacother. 1999;  53 446-470
• 15 Kenner KA, Anyanwu E, Olefsky JM, Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.  J Biol Chem. 1996;  271 19810-19816
• 16 Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Krongrad AS, Shulman GI, Neel BG, Kahn BB. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice.  Mol Cell Biol. 2000;  20 5479-5489
• 17 Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications.  N Engl J Med. 1991;  325 938-948
• 18 Müssig K, Strack V, Häring HU, Kellerer M. The role of Shp2 serine residues 576 and 591 in insulin signaling.  Exp Clin Endocrinol Diabetes. 2004;  S1
• 19 Roith DL, Zick Y. Recent advances in our understanding of insulin action and insulin resistance.  Diabetes Care. 2001;  24 588-597
• 20 Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.  Mol Cell. 2000;  6 1401-1412
• 21 Seely B, Staubs P, Reichart D, Berhanu P, Milarski K, Saltiel A, Kusari J, Olefsky J. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor.  Diabetes. 1996;  45 1379-1385
• 22 Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling.  TRENDS in biology. 2000;  11 437-441

Correspondence